← Back to Patent Explorer
US5834029A Expired / Lapsed US ⏱️ 0.0 years remaining

Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment

Assignee: Neurotech USA Inc
•
Filing: 1994-07-20
•
Granted: 1998-11-10
•
Expires: 2014-07-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A bioartificial three-dimensional hydrogel extracellular matrix derivatized with a cell adhesive peptide fragment is provided for use in tissue regeneration or replacement. The choice of adhesive peptide fragment depends on the desired target cell type. Cartilage or tendon can be regenerated by implanting a matrix containing adhesive peptide fragments that favor chondrocyte invasion. The matrix can be pre-seeded with cells, and tissue can be reconstituted in vitro and then implanted. A cell-seeded matrix can be encapsulated in a semi-permeable membrane to form a bioartificial organ. An agarose hydrogel matrix having an agarose concentration of 0.5-1.25% (w/v) and an average gel pore radius between 120 nm and 290 nm is preferred. The peptide fragment preferably contains the sequence, ArgGlyAsp or TyrIleGlySerArg or IleLysValAlaVal, and is covalently immobilized to the matrix. A nerve guidance channel for use in regenerating severed nerve is prepared containing a tubular semi-permeable membrane having openings adapted to receive the ends of a severed nerve, and an inner lumen containing the matrix having an adhesive peptide fragment through which the nerve can regenerate.

Inventors

  • 👤 Ravi Bellamkonda
  • 👤 John P. Ranieri
  • 👤 Patrick Aebischer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 10:13
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/38; A61L27/3839; A61L27/14; A61L27/20; A61L27/22; A61L27/227; A61L27/50; A61L27/52; A61L31/00; A61L31/005; A61L31/04; A61L31/043; A61L31/047; A61P; A61P25/00; A61P43/00; C; C07; C07K; C07K14/00; C07K14/435; C07K14/78; A61K; A61K38/00; A61L2430/00; A61L2430/32; Y; Y10; Y10S; Y10S530/00; Y10S530/81; Y10S530/812; Y10S530/813

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 145 words
A nerve guidance channel for use in regenerating a severed nerve, comprising: a) a tubular, biocompatible, semi-permeable membrane, said membrane having openings adapted to receive the ends of the severed nerve, and an inner lumen through which the nerve may regenerate, and b) a bioartificial three-dimensional hydrogel extracellular matrix disposed in the lumen of the semi-permeable membrane, wherein the hydrogel is derivatized throughout the matrix with a cell adhesive peptide fragment selected from the group consisting of an RGD-containing sequence comprising ArgGlyAsp; AA 2 -AA 4 of SEQ ID NO: 2, a YIGSR-containing sequence comprising TyrIleGlySerArg; AA 5 -AA 9 of SEQ ID NO: 1, an IKVAV-containing sequence comprising IleLysValAlaVal; AA 11 -AA 15 of SEQ ID NO: 3, and a combination of any of the foregoing sequences, and wherein the average gel pore radius of the matrix is between 120 nm and 290 nm.
Claim 2
Dependent Claim 145 words
A nerve guidance channel for use in regenerating a severed nerve, comprising: a) a tubular, biocompatible, semi-permeable membrane, said membrane having openings adapted to receive the ends of the severed nerve, and an inner lumen through which the nerve may regenerate, and b) a bioartificial three-dimensional hydrogel extracellular matrix disposed in the lumen of the semi-permeable membrane, wherein the hydrogel is derivatized throughout the matrix with a cell adhesive peptide fragment selected from the group consisting of an RGD-containing sequence comprising ArgGlyAsp; AA 2 -AA 4 of SEQ ID NO: 2, a YIGSR-containing sequence comprising TyrIleGlySerArg; AA 5 -AA 9 of SEQ ID NO: 1, an IKVAV-containing sequence comprising IleLysValAlaVal; AA 11 -AA 15 of SEQ ID NO: 3, and a combination of any of the foregoing sequences, and wherein the average gel pore radius of the matrix is between 120 nm and 290 nm.
Claim 3
Dependent Claim 22 words
The nerve guidance channel according to claim 1 wherein the hydrogel is derivatized with the sequence CDPGYIGSR comprising CysAspProGlyTyrIleGlySerArg; SEQ ID NO:1.
Claim 4
Dependent Claim 22 words
The nerve guidance channel according to claim 1 wherein the hydrogel is derivatized with the sequence GRGDSP comprising GlyArgGlyAspSerPro; SEQ ID NO:2.
Claim 5
Dependent Claim 23 words
The nerve guidance channel according to claim 1 wherein the hydrogel is derivatized with the sequence CSRARKQAASIKVAVSADR comprising CysSerArgAlaArgLysGln AlaAlaSerIleLysValAlaValSerAlaAspArg; SEQ ID NO:3.
Claim 6
Dependent Claim 19 words
The nerve guidance channel according to any one of claims 1 and 2-4 wherein the hydrogel is a polysaccharide.
Claim 7
Dependent Claim 13 words
The nerve guidance channel according to claim 5 wherein the hydrogel is agarose.
Claim 8
Dependent Claim 27 words
The nerve guidance channel according to claim 6 wherein the agarose concentration ranges between 0.5-1.25% (w/v) and the average gel pore radius is greater than 120 nm.
Claim 9
Dependent Claim 24 words
The nerve guidance channel according to claim 6 wherein agarose concentration is approximately 1% and the average gel pore radius is approximately 150 nm.
Claim 10
Independent Claim 40 words
A method for promoting in vivo regeneration of a severed nerve comprising securing the proximal and distal ends of the severed nerve into each end of a tubular nerve guidance channel according to any one of claims 1 and 2-8.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-11-09 2002-05-11 2002-11-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-11-09 2006-05-11 2006-11-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-11-09 2010-05-11 2010-11-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag